-

Henry Schein Releases 2022 Sustainability and Corporate Social Responsibility Report, Demonstrating Company’s Commitment to ‘Delivering Solutions for a Healthier Tomorrow’

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, today announced the publication of its 2022 Sustainability and Corporate Social Responsibility (CSR) Report, titled “Delivering Solutions for a Healthier Tomorrow.”

As part of the Company’s work to enhance its disclosures, Henry Schein reported on its sustainability efforts in 2022 in accordance with Sustainability Accounting Standards Board and Global Reporting Initiative Standards. The CSR Report highlights Henry Schein's efforts to promote responsible business practices and make a positive impact on society.

“Throughout Henry Schein’s more than 90 year history, we have remained committed to our five constituents: customers, supplier partners, investors, Team Schein Members, and society at large,” said Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein, Inc. “Guided by our purpose-driven mission and higher ambition model, we continue to operate as a socially responsible and sustainable organization dedicated to ‘Delivering Solutions for a Healthier Tomorrow.’ This year’s Report reflects these commitments, and we look forward to continuing to build on this activity in the years to come.”

To learn more about Henry Schein’s corporate citizenship efforts and to view the full 2022 Sustainability and CSR Report, along with our Reporting Index and second Task Force on Climate-related Financial Disclosures report, please visit www.henryschein.com/corporatecitizenship.

About Henry Schein, Inc.

Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With more than 22,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively.

These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites.

Henry Schein operates through a centralized and automated distribution network, with a selection of more than 300,000 branded products and Henry Schein corporate brand products in our distribution centers.

A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 32 countries and territories. The Company's sales reached $12.6 billion in 2022, and have grown at a compound annual rate of approximately 12.1 percent since Henry Schein became a public company in 1995.

For more information, visit Henry Schein at www.henryschein.com, Facebook.com/HenrySchein, Instagram.com/HenrySchein, and Twitter.com/HenrySchein.

Contacts

Ann Marie Gothard, Vice President, Corporate Media Relations, annmarie.gothard@henryschein.com, (631) 390 – 8169

Henry Schein, Inc.

NASDAQ:HSIC

Release Versions

Contacts

Ann Marie Gothard, Vice President, Corporate Media Relations, annmarie.gothard@henryschein.com, (631) 390 – 8169

More News From Henry Schein, Inc.

Henry Schein Expands Partnership with vVARDIS

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) today announced the expansion of its agreement with vVARDIS, which grants the Company exclusive U.S. distribution rights for the drill-free Curodont™ Repair Fluoride Plus (“Curodont”) product across all dental market segments, effective January 1, 2026. The strategic expansion broadens Henry Schein’s previous exclusivity with the Swiss company, which was announced in 2024 for Dental Service Organizations (DSOs). Starting next ye...

Henry Schein to Participate in Upcoming Investor Conference in December

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc., (Nasdaq: HSIC) the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor conference in December: Piper Sandler’s Healthcare Conference at the Lotte New York Palace Hotel, New York, on December 2, 2025, at 9:00 a.m. Eastern time. Henry Schein’s presentations can be heard via live webcast by visiting www.henryschein.com/IRwebcas...

Henry Schein Reports Record Third Quarter 2025 Financial Results and Raises Full Year Non-GAAP EPS Guidance

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, today reported financial results for the third quarter ended September 27, 2025. “We are pleased with our financial results for the third quarter, with sales growth accelerating in each of our reportable segments including solid market share gains in our distribution businesses as we are once again focused on driving growth n...
Back to Newsroom